Alife

Alife is a private, commercial-stage company providing an AI software-as-a-service (SaaS) platform for fertility clinics. Its core product, Alife Assist™, integrates with existing clinic EMRs to offer modules for standardizing embryo analysis (Embryo Assist), optimizing procedure scheduling (Schedule Predict), and automating patient communication (Success Predictor). The company is backed by peer-reviewed research and is focused on demonstrating improved clinic efficiency, reduced costs, and better patient outcomes through data-driven decision support.

Alife Assist™: A cloud-based, AI-powered software platform that integrates with clinic EMRs. It uses interpretable machine learning models to analyze clinical and embryological data, providing decision-support tools for embryo grading (Embryo Assist), procedure scheduling (Schedule Predict), and patient communication (Success Predictor).

Alife operates in the competitive AI-for-fertility software space, competing with companies like Future Fertility (oocyte assessment), Fairtility (embryo AI), and larger medtech firms developing digital tools. Its differentiators are its integrated multi-module platform, emphasis on interpretable AI, and seamless EMR integration without new hardware requirements.